Abstract
Integration of viral DNA into the host cell genome is an obligatory process for successful replication of HIV-1. Integrase catalyzes the insertion of viral DNA into the target DNA and is a validated target for drug discovery. Herein, we report the synthesis, antiviral activity and pharmacokinetic profiles of several C2-carbon-linked heterocyclic pyrimidinone-4-carboxamides that inhibit the strand transfer step of the integration process.
Keywords:
HIV-1; Inhibitor; Integrase; Pyrimidine-4-carboxamide; Strand transfer.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amides / chemical synthesis
-
Amides / chemistry*
-
Amides / pharmacokinetics
-
Animals
-
HIV Integrase / chemistry*
-
HIV Integrase / metabolism
-
HIV Integrase Inhibitors / chemical synthesis*
-
HIV Integrase Inhibitors / chemistry
-
HIV Integrase Inhibitors / pharmacokinetics
-
HIV-1 / drug effects
-
HIV-1 / enzymology*
-
Half-Life
-
Heterocyclic Compounds / chemistry
-
Humans
-
Male
-
Pyrimidines / chemistry
-
Rats
-
Rats, Sprague-Dawley
-
Structure-Activity Relationship
Substances
-
Amides
-
HIV Integrase Inhibitors
-
Heterocyclic Compounds
-
Pyrimidines
-
HIV Integrase
-
pyrimidine
-
p31 integrase protein, Human immunodeficiency virus 1